Hologic, Inc. (NASDAQ:HOLX) was in 31 hedge funds’ portfolio at the end of December. HOLX shareholders have witnessed a decrease in activity from the world’s largest hedge funds of late. There were 33 hedge funds in our database with HOLX holdings at the end of the previous quarter.
If you’d ask most market participants, hedge funds are assumed to be unimportant, old financial vehicles of yesteryear. While there are greater than 8000 funds trading today, we at Insider Monkey choose to focus on the moguls of this group, close to 450 funds. It is widely believed that this group controls the majority of all hedge funds’ total capital, and by keeping an eye on their highest performing stock picks, we have uncovered a few investment strategies that have historically outstripped the broader indices. Our small-cap hedge fund strategy outpaced the S&P 500 index by 18 percentage points per annum for a decade in our back tests, and since we’ve began to sharing our picks with our subscribers at the end of August 2012, we have topped the S&P 500 index by 25 percentage points in 6.5 month (see the details here).
Just as key, optimistic insider trading sentiment is a second way to break down the stock market universe. As the old adage goes: there are lots of reasons for a bullish insider to cut shares of his or her company, but just one, very clear reason why they would initiate a purchase. Plenty of empirical studies have demonstrated the valuable potential of this tactic if you understand what to do (learn more here).
Now, we’re going to take a peek at the key action regarding Hologic, Inc. (NASDAQ:HOLX).
What does the smart money think about Hologic, Inc. (NASDAQ:HOLX)?
At year’s end, a total of 31 of the hedge funds we track held long positions in this stock, a change of -6% from the previous quarter. With hedgies’ sentiment swirling, there exists a few notable hedge fund managers who were upping their holdings significantly.
When looking at the hedgies we track, John Osterweis’s Osterweis Capital Management had the most valuable position in Hologic, Inc. (NASDAQ:HOLX), worth close to $70 million billion, accounting for 3.1% of its total 13F portfolio. Coming in second is Sectoral Asset Management, managed by Jérôme Pfund and Michael Sjöström, which held a $56 million position; 0.1% of its 13F portfolio is allocated to the company. Other hedgies that hold long positions include Jim Simons’s Renaissance Technologies, D. E. Shaw’s D E Shaw and Jacob Gottlieb’s Visium Asset Management.
Seeing as Hologic, Inc. (NASDAQ:HOLX) has faced a declination in interest from the entirety of the hedge funds we track, it’s easy to see that there is a sect of funds that slashed their entire stakes at the end of the year. At the top of the heap, Daniel S. Och’s OZ Management dumped the biggest position of the 450+ funds we key on, valued at an estimated $39 million in stock., and Alec Litowitz and Ross Laser of Magnetar Capital was right behind this move, as the fund cut about $28 million worth. These transactions are important to note, as total hedge fund interest dropped by 2 funds at the end of the year.
How have insiders been trading Hologic, Inc. (NASDAQ:HOLX)?
Insider trading activity, especially when it’s bullish, is particularly usable when the company in focus has experienced transactions within the past 180 days. Over the last 180-day time frame, Hologic, Inc. (NASDAQ:HOLX) has experienced zero unique insiders purchasing, and 9 insider sales (see the details of insider trades here).
With the returns shown by Insider Monkey’s strategies, retail investors should always keep an eye on hedge fund and insider trading activity, and Hologic, Inc. (NASDAQ:HOLX) shareholders fit into this picture quite nicely.
Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.